| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/10/2012 | US20120114555 Method for treating immune disorders |
| 05/10/2012 | DE102010048800A1 Chinoxalinderivate Quinoxaline derivatives |
| 05/10/2012 | CA2816912A1 Mmp8 inactivating antigen binding proteins |
| 05/10/2012 | CA2816454A1 Enhancement of pathogen-specific memory th17 cell responses |
| 05/10/2012 | CA2815445A1 5 -cyano-4, 6 -diaminopyrimidine or 6 -aminopurine derivatives as pi3k-delta inhibitors |
| 05/10/2012 | CA2815266A1 Stable heterodimeric antibody design with mutations in the fc domain |
| 05/09/2012 | EP2448938A1 Pyrimidinones as pi3k inhibitors |
| 05/09/2012 | EP2448594A1 Dermaseptin b2 used as an inhibitor of the growth of a tumor |
| 05/09/2012 | EP2321284B1 Sulfone substituted quinazoline derivatives as immune-modulators for the treatment of inflammatory and allergic diseases |
| 05/09/2012 | EP2213292B1 Double-stranded oligonucleotides |
| 05/09/2012 | EP1613588B1 2-propylidene-19-nor-vitamin d compounds |
| 05/09/2012 | EP1501467B1 Heterocyclo inhibitors of potassium channel function |
| 05/09/2012 | EP1492813B1 OX40R binding agents |
| 05/09/2012 | EP1492536B1 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
| 05/09/2012 | EP1441589B1 Stable liquid pharmaceutical formulation of igg antibodies |
| 05/09/2012 | CN1735629B Single domain antibodies directed against tumor necrosis factor alpha and uses therefor |
| 05/09/2012 | CN102448990A Adenylyl cyclase-associated protein (CAP1) and uses thereof as a target for immuno-modulation |
| 05/09/2012 | CN102448982A Compositions and methods for modulating the activity of complement regulatory proteins on target cells |
| 05/09/2012 | CN102448949A Heterocyclic compound and hematopoietic stem cell amplifier |
| 05/09/2012 | CN102448487A Vaccination methods |
| 05/09/2012 | CN102448485A Immunogenic composition and uses thereof |
| 05/09/2012 | CN102443526A Chinese medicinal health wine |
| 05/09/2012 | CN102443517A Chinese herbal medicinal health wine for stomach strengthening and spleen invigorating and preparation method thereof |
| 05/09/2012 | CN102443063A Anti-TNFalpha humanized Fab, humanized antibody and its application |
| 05/09/2012 | CN102442995A Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
| 05/09/2012 | CN102442970A Novel compounds as cannabinoid receptor ligands and uses thereof |
| 05/09/2012 | CN102442942A Polymorphic substances of 4-aminopyridine, and preparation and application thereof |
| 05/09/2012 | CN102442941A Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents |
| 05/09/2012 | CN102442918A Stable levocarnitine compound |
| 05/09/2012 | CN102442237A Automobile cushion |
| 05/09/2012 | CN102441177A Nano bubble carrier for small interfering ribonucleic acid (siRNA) transfer |
| 05/09/2012 | CN102441163A Tweak binding antibodies |
| 05/09/2012 | CN102441160A Thymosin alpha1 medicinal composition and preparation method thereof |
| 05/09/2012 | CN102441159A Application of human polypeptide in preparation of immune regulator |
| 05/09/2012 | CN102441157A Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder |
| 05/09/2012 | CN102441153A Recuperating oral liquid and manufacturing method thereof |
| 05/09/2012 | CN102441134A Chinese herbal medicinal composition, preparation, and preparation method and application thereof |
| 05/09/2012 | CN102441093A Medicine for lowering transplant renal arterial resistance index |
| 05/09/2012 | CN102441090A Immunoregulation oral liquid |
| 05/09/2012 | CN102441071A Healthcare oral liquid |
| 05/09/2012 | CN102441059A Ginseng chrysanthemum-prepared health-care sucking product capable of strengthening immunity |
| 05/09/2012 | CN102441045A Method for making Chinese medicinal wine for regulating qi and blood and nourishing spleen and stomach |
| 05/09/2012 | CN102441036A Medicament prescription for treating allergic rhinitis |
| 05/09/2012 | CN102441034A Medicine for treating allergic rhinitis |
| 05/09/2012 | CN102441021A Method for preparing honeysuckle extract by using size exclusion chromatography |
| 05/09/2012 | CN102441000A Anti-cancer anti-disease buccal tablet |
| 05/09/2012 | CN102440999A Compound drug for preventing and curing iron-deficiency anemia and low anaphylaxis |
| 05/09/2012 | CN102440973A Diphenhydramine citrate orally disintegrating tablet and preparation method thereof |
| 05/09/2012 | CN102440962A Paeonol micro depot carrier and method for enhancing oxidation resistance of paeonol |
| 05/09/2012 | CN102440959A Pidotimod liposome solid preparation |
| 05/09/2012 | CN102440612A Mosquito-repelling odor-removing health-care bed sheet |
| 05/09/2012 | CN102133389B Traditional Chinese medicine for reducing incidence rate and death rate of infectious disease of livestock and poultry |
| 05/09/2012 | CN102100725B Preparation technology of extracting total alkaloid extraction from Gansu whin |
| 05/09/2012 | CN101831355B Nutmeg compound essential oil |
| 05/09/2012 | CN101804061B New methylprednisolone tablets and crystal form and preparation method thereof |
| 05/09/2012 | CN101628921B Preparation method of plant source D-glucosamine hydrochloride |
| 05/09/2012 | CN101511796B Imidazole derivative |
| 05/09/2012 | CN101496603B Health-care food with enhancing immunity and antioxidation functions |
| 05/09/2012 | CN101439059B Ginkgo leaf extract drop and preparation method thereof |
| 05/08/2012 | US8173786 Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same |
| 05/08/2012 | US8173782 Fusion protein comprising growth hormone and growth hormone receptor |
| 05/08/2012 | US8173663 Dipeptidyl peptidase inhibitors |
| 05/08/2012 | US8173662 Fused pyrimidines as inhibitors of nucleoside phosphorylases and nucleosidases |
| 05/08/2012 | US8173133 Acyl pseudodipeptides which carry a functionalized auxiliary arm |
| 05/08/2012 | US8173129 Methods and compositions for treating autoimmune diseases |
| 05/08/2012 | US8173124 Method to treat using antagonistic anti-hTNFSF13b human antibodies |
| 05/08/2012 | US8173117 Mouse CX3C chemokine polypeptides |
| 05/08/2012 | US8173107 Delivery of antipsychotics through an inhalation route |
| 05/08/2012 | CA2492153C Production of polyketide fkbp-ligand analogues |
| 05/08/2012 | CA2469334C Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 05/08/2012 | CA2460042C Inhibition of antigen presentation with poorly catabolized polymers |
| 05/08/2012 | CA2378888C Method for enhancing production performance in an animal |
| 05/08/2012 | CA2368184C Method and means for treating post-polio syndrome |
| 05/08/2012 | CA2362264C Cytokine-binding domain |
| 05/08/2012 | CA2350064C Chimeric anti-cd20 antibody treatment of patients receiving bmt or pbsc transplants |
| 05/08/2012 | CA2284271C A preventive or therapeutic agent for sensitized t cell-mediated diseases comprising il-6 antagonist as an active ingredient |
| 05/08/2012 | CA2266859C Colostrinin, and uses thereof |
| 05/08/2012 | CA2229741C Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology |
| 05/08/2012 | CA2163211C Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
| 05/03/2012 | WO2012058254A1 Benzimidazole inhibitors of leukotriene production |
| 05/03/2012 | WO2012057671A1 New compositions and methods for treatment of autoimmune and allergic diseases |
| 05/03/2012 | WO2012057262A1 Pyridine derivative and medicinal agent |
| 05/03/2012 | WO2012056229A1 Inflammatory disease |
| 05/03/2012 | WO2012056048A1 Treatment of inflammation |
| 05/03/2012 | WO2012055880A1 Method of treatment based on atad2 inhibitors |
| 05/03/2012 | WO2012055879A1 Method of treatment by inhibition of baz1b |
| 05/03/2012 | WO2012055846A1 Polymorphs and salts of 6-(1h-indol-4-yl)-4-(5- { [4-(1-methylethyl)-1-pi perazinyl] methyl} -1,3-oxazol-2-yl)-1h-indazole as pi3k inhibitors for use in the treatment of e.g. respiratory disorders |
| 05/03/2012 | WO2012055205A1 Pegylated recombinant consensus interferon variant conjugate and preparation mehtod and uses thereof |
| 05/03/2012 | WO2012025831A3 Salmonella vaccine proteins |
| 05/03/2012 | WO2012002762A3 Peptide for the treatment or prevention of allergic diseases |
| 05/03/2012 | WO2011150320A3 Activators of innate immunity |
| 05/03/2012 | WO2011120013A3 Vista regulatory t cell mediator protein, vista binding agents and use thereof |
| 05/03/2012 | WO2011041847A8 Chaperonin 10 variants |
| 05/03/2012 | US20120108638 Pyridin-4-yl derivatives |
| 05/03/2012 | US20120108631 Sulfonamides for the Modulation of PKM2 |
| 05/03/2012 | US20120108627 Imidazo [4,5-c]quinoline derivatives and their use in the treatment of tumors and/or inflammation |
| 05/03/2012 | US20120108618 Thia-triaza-indacenes |
| 05/03/2012 | US20120108616 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors |
| 05/03/2012 | US20120108612 Inhibitors of bruton's tyrosine kinase |
| 05/03/2012 | US20120108605 O-glcnac transferase inhibitors and uses thereof |